-
FDA Grants Orphan Drug Designation for Tinostamustine in Malignant Glioma
11 Nov 2025 07:37 GMT
… with glioblastoma, the most common malignant glioma, that is aggressive, very challenging …
-
Exousia’s candidate for malignant glioma gains US orphan drug status
29 Oct 2025 22:55 GMT
-
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
10 Nov 2025 12:00 GMT
… FDA for the treatment of malignant glioma and from the European Commission …
-
Hemispherian’s GLIX-1 awarded US orphan drug designation for malignant glioma
01 Jul 2025 16:16 GMT
Home » Hemispherian’s GLIX-1 awarded US orphan drug designation for malignant glioma
Cancer
GLIX-1 is a first-in-class small-molecule therapeutic targeting DNA repair vulnerabilities in cancer cells.
BioWorld Science Regulatory Cancer FDA Orphan drug
-
Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma
01 Jul 2025 07:33 GMT
… GLIX1 for the treatment of malignant glioma, a category of devastating brain … meaningful benefit to patients with malignant glioma."
About the Designation
The … -glix1-for-the-treatment-of-malignant-glioma-302494723.html
SOURCE Hemispherian AS
-
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
07 Nov 2025 14:00 GMT
… patients with recurrent high grade malignant glioma. The discussion will highlight MRI …
-
ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting
28 Apr 2025 03:11 GMT
… ;) product MVR-C5252 targeting malignant glioma through poster presentation at American … .
According to industry data, malignant glioma, a highly aggressive and recurrent … oncolytic-product-mvr-c5252-targeting-malignant-glioma-via-convection-enhanced-delivery- …
-
ICAM1-Mediated Endothelial Cells and Macrophage Interactions in Modulating GBM Malignant Transformation
04 Nov 2025 20:24 GMT
… mural cells promotes neovascularization in malignant glioma. Oncogene. 2017;36(38):5356 …
-
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
04 Nov 2025 21:00 GMT
… FDA for the treatment of malignant glioma and from the European Commission …
-
Malignant glioma diagnosed earlier in men
29 Jan 2025 21:15 GMT
… .
An analysis of adults with malignant glioma revealed that men were diagnosed … out of Germany found that malignant glioma tends to be diagnosed earlier … and sex-related differences in malignant glioma epidemiology and outcomes among patients …
About
© 1995-2025